Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum

Sun, XunLi, KexinHase, MisatoZha, RongrongFeng, YanLi, Bai-YanYokota, Hiroki2023-10-182023-10-182023-01-01Sun X, Li K, Hase M, et al. Erratum: Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum. Theranostics. 2023;13(1):16-19. Published 2023 Jan 1. doi:10.7150/thno.79085https://hdl.handle.net/1805/36437[This corrects the article DOI: 10.7150/thno.66148.].en-USAttribution 4.0 InternationalBreast cancerOsteoblastsHsp90ab1MoesinCD44Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: ErratumArticle